Vlado Perkovic's Publications

About Vlado Perkovic's Publications

Board Member
  • MBBS,
  • PhD,
  • FASN,
  • FRACP

  • First plus recurrent CV and hospitalization events in the CArdiovascular and Renal Microvascular outcomE study with LINAgliptin (CARMELINA) in patients with type 2 diabetes and cardiorenal disease

    Date published:

  • Interrelationship between hypoglycemia and CV and mortality outcomes in type 2 diabetes in the CARMELINA Trial

    Date published:

  • SGLT2 inhibitor lowers risk of kidney failure in type 2 diabetes

    Pharmaceutical Journal Date published:

  • Randomised controlled trial of the impact of haemodiafiltration on uraemic neuropathy: FINESSE study protocol

    BMJ Open Date published:

  • Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus

    Hypertension Date published:

  • Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk

    JAMA Date published:

  • China Kidney Disease Network (CK-NET) 2015 Annual Data Report

    Kidney International Supplements Date published:

  • Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop

    Kidney International Date published:

  • Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial

    The Lancet Diabetes & Endocrinology Date published:

  • New hypoglycemic agents and the kidney: what do the major trials tell us?

    F1000Research Date published:

  • Glucose lowering and the kidney: are all drug classes equal?

    The Lancet Diabetes & Endocrinology Date published:

  • Reducing cardiovascular risk in people with diabetes and kidney disease

    Medical Journal of Australia Date published:

  • ACCORDION: Ensuring That We Hear the Music Clearly

    Clinical Journal of the American Society of Nephrology Date published:

  • Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function

    Circulation Date published:

  • Canagliflozin and cardiovascular outcomes in patients with chronic kidney disease

    Date published:

  • New clinical trial designs for establishing drug efficacy and safety in a precision medicine era

    Diabetes, Obesity and Metabolism Date published: